1-6 of 6
Emily Dotson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Gemcitabine and Liposomal Doxorubicin (GemDox) for the Treatment of Relapsed and Refractory T-Cell Lymphomas

Zachary Braunstein, Allyson Waller, Emily Dotson, Eric McLaughlin, Walter Hanel, John C Reneau, Daniel Addison, Pierluigi Porcu, Jonathan E. Brammer
Journal: Blood
Blood (2023) 142 (Supplement 1): 4453.
https://doi.org/10.1182/blood-2023-184583
Published: 2023
Journal Articles

Outcomes of Patients with Diffuse Large B Cell and High-Grade B Cell Lymphomas with Synchronous CNS and Systemic Involvement at Diagnosis Treated with High-Dose Methotrexate and R-CHOP: A Single-Center Retrospective Study

Megan Fleming, Ying Huang, Emily Dotson, David A. Bond, John C. Reneau, Narendranath Epperla, Jonathan E. Brammer, Beth Christian, Lapo Alinari, Robert Baiocchi, Kami J. Maddocks, Yazeed Sawalha
Journal: Blood
Blood (2021) 138 (Supplement 1): 1425.
https://doi.org/10.1182/blood-2021-148662
Published: 2021
Journal Articles

Rapid Dose Escalation of Venetoclax in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Previously Treated with B-Cell Receptor Inhibitor Therapy

Kristin Koenig, MD, Emily Dotson, PharmD, Shane Sheredy, Seema A. Bhat, MD, John C. Byrd, MD, Tracy Wiczer, Jennifer Woyach, MD, Farrukh T. Awan, MD, Kerry A. Rogers, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3045.
https://doi.org/10.1182/blood-2019-124538
Published: 2019
Journal Articles

Ingle-Institutional Experience with the Use of PD-1 Inhibitors for the Treatment of Richter's Syndrome

Kerry A. Rogers, MD, Ying Huang, MA, MS, Emily Dotson, PharmD, Jordan Lundberg, PharmD, Leslie Andritsos, MD, Farrukh T. Awan, MD MS, Jeffrey A. Jones, MD MPH, MBA, Jennifer A. Woyach, MD, John C. Byrd, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5345.
https://doi.org/10.1182/blood.V130.Suppl_1.5345.5345
Published: 2017
Journal Articles

Major Bleeding Complications Among Patients Treated with Ibrutinib and Concomitant Antiplatelet, Anticoagulant, or Supplemental Therapy

Aaron Pavlik, PharmD, Hallie Barr, PharmD, BCOP, Emily Dotson, PharmD, BCOP, John C. Byrd, MD, Kristie A. Blum, MD, Farrukh T. Awan, Jennifer A. Woyach, MD, Kami J. Maddocks, MD, Beth A Christian, MD, Jeffrey Jones, MD MPH
Journal: Blood
Blood (2016) 128 (22): 4387.
https://doi.org/10.1182/blood.V128.22.4387.4387
Published: 2016
Journal Articles

Assessment Of Hypersensitivity Reactions and Feasibility Of a 60 Minute Rapid Infusion Rituximab Protocol At a Comprehensive Cancer Center

Emily Dotson, PharmD, BCOP, Brooke Crawford, PharmD, BCOP, Gary Phillips, MAS, Jeffrey A. Jones, MD, MPH
Journal: Blood
Blood (2013) 122 (21): 2985.
https://doi.org/10.1182/blood.V122.21.2985.2985
Published: 2013